Old Web
English
Sign In
Acemap
>
authorDetail
>
Cheryl A. Borgman
Cheryl A. Borgman
University of Virginia Health System
Pancreatic cancer
KRAS
Lapatinib
Molecular biology
MEK inhibitor
4
Papers
88
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Inhibition of the Growth of Patient-Derived Pancreatic Cancer Xenografts with the MEK Inhibitor Trametinib Is Augmented by Combined Treatment with the Epidermal Growth Factor Receptor/HER2 Inhibitor Lapatinib
2013
Neoplasia
Dustin M. Walters
James M. Lindberg
Sara J. Adair
Timothy E. Newhook
Catharine R. Cowan
Jayme B. Stokes
Cheryl A. Borgman
Edward B. Stelow
Bryce T. Lowrey
Maria E. Chopivsky
Tona M. Gilmer
J.T. Parsons
Todd W. Bauer
Show All
Source
Cite
Save
Citations (68)
Mass spectrometric analysis identifies a cortactin–RCC2/TD60 interaction in mitotic cells
2012
Journal of Proteomics
Pablo R. Grigera
Li Ma
Cheryl A. Borgman
Antonio Frederico Michel Pinto
Nicholas E. Sherman
J. Thomas Parsons
Jay W. Fox
Show All
Source
Cite
Save
Citations (20)
Acquired resistance to combination therapy with lapatinib and MEK 1/2 inhibitor GSK1120212 in an in vivo murine model of pancreatic cancer.
2012
Journal of Clinical Oncology
James M. Lindberg
Dustin M. Walters
Sara J. Adair
Catharine R. Cowan
Jayme B. Stokes
Cheryl A. Borgman
Edward B. Stelow
Bryce Lowrey
Maria E. Chopivsky
J. Thomas Parsons
Todd W. Bauer
Show All
Source
Cite
Save
Citations (0)
Abstract 1592: Targeting proliferative signals in patient-derived pancreatic cancers propagated orthotopically in immunocompromised mice
2011
Cancer Research
Dustin M. Walters
Catharine R. Cowan
Sara J. Adair
Cheryl A. Borgman
Jayme B. Stokes
Edward B. Stelow
Bryce Lowrey
Tona M. Gilmer
J. Thomas Parsons
Todd W. Bauer
Show All
Source
Cite
Save
Citations (0)
1